📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A randomized phase 3 trial of interferon-a vs hydroxyurea in polycythemia vera and essential thrombocythemia. (2022)

First Author: Mascarenhas J

Attributed to: The Oxford Single Cell Biology Consortium funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2021012743

PubMed Identifier: 35007321

Publication URI: http://europepmc.org/abstract/MED/35007321

Type: Journal Article/Review

Volume: 139

Parent Publication: Blood

Issue: 19

ISSN: 0006-4971